Melanocortin System Activation Leads to Sustained Weight Loss Without Dieting

The global prevalence of obesity continues to rise, posing significant health risks and placing immense strain on healthcare systems. Current strategies primarily rely on caloric restriction and increased physical activity, but maintaining body mass reduction long-term proves challenging for many individuals, often leading to weight regain. This study specifically aimed to investigate whether activating the central melanocortin system could provide a novel and effective mechanism for chronic body mass reduction independent of continuous dietary intervention.

The Melanotan II treated group exhibited a highly significant and sustained reduction in body mass compared to the control group. During the initial 4-week treatment phase, treated rats lost an average of 15% of their initial body weight, whereas control rats gained 5% (p<0.001), demonstrating a robust acute effect. Crucially, even after the cessation of Melanotan II administration, the treated group maintained a 12% lower body weight than controls for the subsequent 8 weeks, showcasing a persistent effect without ongoing drug exposure. Food intake in the treated group was initially reduced by 20% during active treatment, but remarkably returned to control levels during the observation phase, yet body mass remained significantly lower. Energy expenditure was significantly increased by 18% (p<0.005) in the treated group during the active treatment phase, and remained 8% higher (p<0.01) during the post-treatment observation period, contributing to the sustained weight loss. Furthermore, treated animals showed improved insulin sensitivity, with a 30% reduction in fasting insulin levels (p<0.001) compared to controls, suggesting broader metabolic benefits. The most striking finding was that activation of the central melanocortin system led to a 12% sustained reduction in body mass for 8 weeks post-treatment, without requiring continuous caloric restriction or drug administration.